11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational Modeling

被引:5
作者
Liu, Haifeng [1 ]
Li, Lingyu [1 ]
Zhang, Chunlei [1 ]
Li, Hongzhi [1 ]
Liu, Jieting [1 ]
Tang, Chunyin [1 ]
Zhang, Yufei [1 ]
Wu, Dan [1 ]
Chu, Yanhui [1 ]
Wu, Yan [1 ]
Yuan, Xiaohuan [1 ]
机构
[1] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang 157011, Peoples R China
关键词
11 beta-Hydroxysteroid dehydrogenase type 1; Screening; Recombinant plasmids; Lentiviral transduction; Computational modeling; 11-BETA-HSD1; DISCOVERY; OBESITY;
D O I
10.1159/000491397
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, rat and human 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) have been cloned by lentiviral transduction and expressed by CHO-K1 cells. The results showed that recombinant plasmids contained R11bhsd1orH11bhsd1 have been constructed, which is consistent with the gene bank respectively. A clone cell was selected with G418 and cultivated to express 11 beta-HSD1. 11 beta-HSD1 catalytic activity of rat and human were 99.5 and 98.7%, respectively, determined by scanning radiometer. And the cloned CHO-K1 cells expressed the protein of 11 beta-HSD1 in a long-term and stable manner, which makes it suitable for screening 11 beta-HSD1 inhibitor. The three-dimensional structure of 11 beta-HSD1 was used for studying the interaction between inhibitor and enzyme by the binding poses predicted by AutoDock and LeDock software. The docking results revealed that compound 8 forms 2 hydrogen bonds with the residues of Gly-216 and Ile-218 in 11 beta-HSD1, that is to say compound 8 maybe a good 11 beta-HSD1 inhibitor. Moreover, C57BL/6 mice with R11bHsd1 overexpression had a higher body weight, glucose, total cholesterol, and triglyceride levels compared to the mice treated with an empty viral vector. The results might provide a beneficial foundation for selecting inhibitors of 11 beta-HSD1 or for researching drug candidate mechanisms. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:169 / 179
页数:11
相关论文
共 31 条
[1]  
AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
[2]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[3]  
[Anonymous], 2016, P WORKSH
[4]   Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 [J].
Barf, T ;
Vallgårda, J ;
Emond, R ;
Häggström, C ;
Kurz, G ;
Nygren, A ;
Larwood, V ;
Mosialou, E ;
Axelsson, K ;
Olsson, R ;
Engblom, L ;
Edling, N ;
Rönquist-Nii, Y ;
Öhman, B ;
Alberts, P ;
Abrahmsén, L .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3813-3815
[5]   Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4′-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11β-hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys [J].
Bhat, B. Ganesh ;
Hosea, Natilie ;
Fanjul, Andrea ;
Herrera, Jocelyn ;
Chapman, Justin ;
Thalacker, Fred ;
Stewart, Paul M. ;
Rejto, Paul A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (01) :299-305
[6]   Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-β hydroxysteroid dehydrogenase type 1 [J].
Chang, Ling-Ling ;
Wun, Wan-Song A. ;
Wang, Paulus S. .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2016, 44 :1-12
[7]   Establishing the first institutional animal care and use committee in Egypt [J].
Fahmy, Sohair R. ;
Gaafar, Khadiga .
PHILOSOPHY ETHICS AND HUMANITIES IN MEDICINE, 2016, 11
[8]   Hypothalamic-Pituitary-Adrenal (HPA) Axis and Aging [J].
Guptaand, Deepashree ;
Morley, John E. .
COMPREHENSIVE PHYSIOLOGY, 2014, 4 (04) :1495-1510
[9]   11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice [J].
Hermanowski-Vosatka, A ;
Balkovec, JM ;
Cheng, K ;
Chen, HY ;
Hernandez, M ;
Koo, GC ;
Le Grand, CB ;
Li, ZH ;
Metzger, JM ;
Mundt, SS ;
Noonan, H ;
Nunes, CN ;
Olson, SH ;
Pikounis, B ;
Ren, N ;
Robertson, N ;
Schaeffer, JM ;
Shah, K ;
Springer, MS ;
Strack, AM ;
Strowski, M ;
Wu, K ;
Wu, TJ ;
Xiao, JY ;
Zhang, BB ;
Wright, SD ;
Thieringer, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) :517-527
[10]   Inhibitors of 11β-HSD1: A Potential Treatment for the Metabolic Syndrome [J].
Jean, David J. St., Jr. ;
Wang, Minghan ;
Fotsch, Christopher .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (17) :1508-1523